A BILL 
To authorize the Attorney General to make grants to, and 
enter into cooperative agreements with, States and units 
of local government to develop, implement, or expand 
one or more programs to provide medication-assisted 
treatment to individuals who have opioid use disorder 
and are incarcerated within the jurisdictions of the 
States or units of local government. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
01:31 Oct 28, 2021
H5697
2 
•HR 5697 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Community Re-Entry 
2
through Addiction Treatment to Enhance Opportunities 
3
Act’’ or as the ‘‘CREATE Opportunities Act’’. 
4
SEC. 2. MEDICATION-ASSISTED TREATMENT CORRECTIONS 
5
AND COMMUNITY REENTRY PROGRAM. 
6
(a) DEFINITIONS.—In this section— 
7
(1) the term ‘‘Attorney General’’ means the At-
8
torney General, acting through the Director of the 
9
National Institute of Corrections; 
10
(2) the term ‘‘certified recovery coach’’ means 
11
an individual— 
12
(A) with knowledge of, or experience with, 
13
recovery from a substance use disorder; and 
14
(B) who— 
15
(i) has completed training through, 
16
and is determined to be in good standing 
17
by— 
18
(I) a single State agency; or 
19
(II) a recovery community orga-
20
nization that is capable of conducting 
21
that training and making that deter-
22
mination; and 
23
(ii) meets the criteria specified by the 
24
Attorney General, in consultation with the 
25
Secretary of Health and Human Services, 
26
01:31 Oct 28, 2021
H5697
3 
•HR 5697 IH
for qualifying as a certified recovery coach 
1
for the purposes of this Act; 
2
(3) the term ‘‘correctional facility’’ has the 
3
meaning given the term in section 901 of title I of 
4
the Omnibus Crime Control and Safe Streets Act of 
5
1968 (34 U.S.C. 10251); 
6
(4) the term ‘‘covered grant or cooperative 
7
agreement’’ means a grant received, or cooperative 
8
agreement entered into, under the Program; 
9
(5) the term ‘‘covered program’’ means a pro-
10
gram— 
11
(A) to provide medication-assisted treat-
12
ment to individuals who have opioid use dis-
13
order and are incarcerated within the jurisdic-
14
tion of the State or unit of local government 
15
carrying out the program; and 
16
(B) that is developed, implemented, or ex-
17
panded through a covered grant or cooperative 
18
agreement; 
19
(6) the term ‘‘medication-assisted treatment’’ 
20
means the use of one or more drugs, or one or more 
21
combinations of drugs, that have been approved 
22
under the Federal Food, Drug, and Cosmetic Act 
23
(21 U.S.C. 301 et seq.) or section 351 of the Public 
24
Health Service Act (42 U.S.C. 262) for the treat-
25
01:31 Oct 28, 2021
H5697
4 
•HR 5697 IH
ment of an opioid use disorder, in combination with 
1
evidence-based counseling and behavioral therapies, 
2
such as psychosocial counseling, overseen by one or 
3
more social work professionals and one or more 
4
qualified clinicians, to provide a comprehensive ap-
5
proach to the treatment of substance use disorders; 
6
(7) the term ‘‘nonprofit organization’’ means an 
7
organization that is described in section 501(c)(3) of 
8
the Internal Revenue Code of 1986 and is exempt 
9
from taxation under section 501(a) of such Code; 
10
(8) the term ‘‘Panel’’ means the Medication-as-
11
sisted Treatment Corrections and Community Re-
12
entry Application Review Panel established under 
13
subsection (e)(2); 
14
(9) the term ‘‘participant’’ means an individual 
15
who participates in a covered program; 
16
(10) the term ‘‘political appointee’’ has the 
17
meaning given the term in section 714(h) of title 38, 
18
United States Code; 
19
(11) the term ‘‘Program’’ means the Medica-
20
tion-Assisted Treatment Corrections and Community 
21
Reentry Program established under subsection (b); 
22
(12) the term ‘‘psychosocial’’ means the inter-
23
relation of social factors and individual thought and 
24
behavior; 
25
01:31 Oct 28, 2021
H5697
5 
•HR 5697 IH
(13) the term ‘‘recovery community organiza-
1
tion’’ has the meaning given the term in section 547 
2
of the Public Health Service Act (42 U.S.C. 290ee– 
3
2); 
4
(14) the term ‘‘single State agency’’ means, 
5
with respect to a State or unit of local government, 
6
the single State agency identified by the State, or 
7
the State in which the unit of local government is 
8
located, in the plan submitted by that State under 
9
section 1932(b)(1)(A)(i) of the Public Health Serv-
10
ice Act (42 U.S.C. 300x–32(b)(1)(A)(i)); 
11
(15) the term ‘‘State’’ means— 
12
(A) each State of the United States; 
13
(B) the District of Columbia; and 
14
(C) each commonwealth, territory, or pos-
15
session of the United States; and 
16
(16) the term ‘‘unit of local government’’ has 
17
the meaning given the term in section 901 of title 
18
I of the Omnibus Crime Control and Safe Streets 
19
Act of 1968 (34 U.S.C. 10251), except that such 
20
term also includes a tribal organization, as defined 
21
in section 4 of the Indian Self-Determination and 
22
Education Assistance Act (25 U.S.C. 5304). 
23
(b) AUTHORIZATION.—Not later than 90 days after 
24
the date of enactment of this Act, the Attorney General, 
25
01:31 Oct 28, 2021
H5697
6 
•HR 5697 IH
in consultation with the Secretary of Health and Human 
1
Services, shall establish a program— 
2
(1) that shall be known as the ‘‘Medication-As-
3
sisted Treatment Corrections and Community Re-
4
entry Program’’; and 
5
(2) under which the Attorney General— 
6
(A) may make grants to, and enter into co-
7
operative agreements with, States or units of 
8
local government to develop, implement, or ex-
9
pand one or more programs to provide medica-
10
tion-assisted treatment that meets the standard 
11
of care generally accepted for the treatment of 
12
opioid use disorder to individuals who have 
13
opioid use disorder and are incarcerated within 
14
the jurisdictions of the States or units of local 
15
government; and 
16
(B) shall establish a working relationship 
17
with one or more knowledgeable corrections or-
18
ganizations with expertise in security, medical 
19
health, mental health, and addiction care to 
20
oversee and support implementation of the pro-
21
gram, including through the use of evidence- 
22
based clinical practices. 
23
(c) PURPOSES.—The purposes of the Program are 
24
to— 
25
01:31 Oct 28, 2021
H5697
7 
•HR 5697 IH
(1) develop medication-assisted treatment pro-
1
grams in consultation with nonprofit organizations 
2
and community organizations that are qualified to 
3
provide technical support for the programs; 
4
(2) reduce the risk of overdose to participants 
5
after the participants are released from incarcer-
6
ation; and 
7
(3) reduce the rate of reincarceration. 
8
(d) PROGRAM REQUIREMENTS.—In carrying out a 
9
covered program, a State or unit of local government 
10
shall— 
11
(1) in providing medication-assisted treatment 
12
under the covered program, offer to participants 2 
13
or more drugs that— 
14
(A) have been approved under the Federal 
15
Food, Drug, and Cosmetic Act (21 U.S.C. 301 
16
et seq.) or section 351 of the Public Health 
17
Service Act (42 U.S.C. 262) for the treatment 
18
of an opioid use disorder; and 
19
(B) do not contain the same active moiety; 
20
and 
21
(2) use— 
22
(A) screening tools with psychometric reli-
23
ability and validity that provide useful clinical 
24
01:31 Oct 28, 2021
H5697
8 
•HR 5697 IH
data to guide the long-term treatment of par-
1
ticipants who have— 
2
(i) opioid use disorder; or 
3
(ii) co-occurring opioid use disorder 
4
and mental disorders; 
5
(B) at each correctional facility at which 
6
the covered program is carried out, a sufficient 
7
number of personnel, as determined by the At-
8
torney General in light of the number of indi-
9
viduals incarcerated at the correctional facility 
10
and the number of those individuals who the 
11
correctional facility has screened and identified 
12
as having opioid use disorder, to— 
13
(i) monitor participants with active 
14
opioid use disorder who begin participation 
15
in 
the 
covered 
program 
while 
dem-
16
onstrating, or develop, signs and symptoms 
17
of opioid withdrawal; 
18
(ii) provide evidence-based medically 
19
managed withdrawal care or assistance to 
20
the participants described in clause (i); 
21
(iii) prescribe or otherwise dispense— 
22
(I) the drugs that are offered 
23
under the covered program, as re-
24
quired under paragraph (1); and 
25
01:31 Oct 28, 2021
H5697
9 
•HR 5697 IH
(II) naloxone or any other emer-
1
gency opioid antagonist approved by 
2
the Commissioner of Food and Drugs 
3
to treat opioid overdose; and 
4
(iv) discuss with participants the risks 
5
and benefits of, and differences among, the 
6
opioid antagonist, opioid agonist, and par-
7
tial agonist drugs used to treat opioid use 
8
disorder; and 
9
(C) a certified recovery coach, social work 
10
professional, or other qualified clinician who, in 
11
order to support the sustained recovery of par-
12
ticipants, shall work with participants who are 
13
recovering from opioid use disorder. 
14
(e) APPLICATION.— 
15
(1) IN GENERAL.—A State or unit of local gov-
16
ernment desiring a covered grant or cooperative 
17
agreement shall submit to the Attorney General an 
18
application that— 
19
(A) shall include— 
20
(i) a description of— 
21
(I) the objectives of the medica-
22
tion-assisted treatment program that 
23
the applicant will develop, implement, 
24
01:31 Oct 28, 2021
H5697
10 
•HR 5697 IH
or expand under the covered grant or 
1
cooperative agreement; 
2
(II) the activities that the appli-
3
cant will carry out under the covered 
4
program; 
5
(III) how the activities described 
6
under subclause (II) will achieve the 
7
objectives described in subclause (I); 
8
and 
9
(IV) the outreach and education 
10
component of the covered program 
11
that the applicant will carry out in 
12
order to encourage maximum partici-
13
pation in the covered program; 
14
(ii) if, under the covered program that 
15
the applicant will carry out, the applicant 
16
will not, in providing medication-assisted 
17
treatment, offer to participants not less 
18
than 1 drug that uses an opioid antago-
19
nist, not less than 1 drug that uses an 
20
opioid agonist, and not less than 1 drug 
21
that uses an opioid partial agonist, an ex-
22
planation of why the applicant is unable to 
23
or chooses not to offer a drug that uses an 
24
opioid antagonist, a drug that uses an 
25
01:31 Oct 28, 2021
H5697
11 
•HR 5697 IH
opioid agonist, or a drug that uses an 
1
opioid partial agonist, as applicable; 
2
(iii) a plan for— 
3
(I) measuring progress in achiev-
4
ing the objectives described in clause 
5
(i)(I), including a strategy to collect 
6
data that can be used to measure that 
7
progress; 
8
(II) collaborating with the single 
9
State agency for the applicant or one 
10
or more nonprofit organizations in the 
11
community of the applicant to help 
12
ensure that— 
13
(aa) if participants so desire, 
14
participants have continuity of 
15
care after release from incarcer-
16
ation with respect to the form of 
17
medication-assisted treatment the 
18
participants received during in-
19
carceration, including— 
20
(AA) by working with 
21
community service providers 
22
to assist eligible partici-
23
pants, before release from 
24
incarceration in registering 
25
01:31 Oct 28, 2021
H5697
12 
•HR 5697 IH
for the Medicaid program 
1
under title XIX of the Social 
2
Security Act (42 U.S.C. 
3
1396 et seq.) or other min-
4
imum essential coverage, as 
5
defined in section 5000A(f) 
6
of 
the 
Internal 
Revenue 
7
Code of 1986; and 
8
(BB) if a participant 
9
cannot afford, or does not 
10
qualify for, health insurance 
11
that provides coverage with 
12
respect to enrollment in a 
13
medication-assisted 
treat-
14
ment program, and if the 
15
participant cannot pay the 
16
cost of enrolling in a medi-
17
cation-assisted 
treatment 
18
program, by working with 
19
units of local government, 
20
nonprofit 
organizations, 
21
opioid use disorder treat-
22
ment providers, and entities 
23
carrying out programs under 
24
substance 
use 
disorder 
25
01:31 Oct 28, 2021
H5697
13 
•HR 5697 IH
grants to, before the partici-
1
pant is released from incar-
2
ceration, identify a resource, 
3
other than the applicant or 
4
the covered program to be 
5
carried out by the applicant, 
6
that may be used to pay the 
7
cost of enrolling the partici-
8
pant in a medication-as-
9
sisted treatment program; 
10
(bb) medications are se-
11
curely stored; and 
12
(cc) protocols relating to di-
13
version are maintained; and 
14
(III) with respect to each com-
15
munity in which a correctional facility 
16
at which a covered program will be 
17
carried out is located, collaborating 
18
with State agencies responsible for 
19
overseeing programs relating to sub-
20
stance use disorder and local public 
21
health officials and nonprofit organi-
22
zations in the community to help en-
23
sure that medication-assisted treat-
24
ment provided at each correctional fa-
25
01:31 Oct 28, 2021
H5697
14 
•HR 5697 IH
cility at which the covered program 
1
will be carried out is also available at 
2
locations that are not correctional fa-
3
cilities in those communities, to the 
4
greatest extent practicable; and 
5
(iv) a certification that— 
6
(I) each correctional facility at 
7
which the covered program will be 
8
carried out has access to a sufficient 
9
number of clinicians who are licensed 
10
to prescribe or otherwise dispense to 
11
participants the drugs for the treat-
12
ment of opioid use disorder required 
13
to be offered under subsection (d)(1), 
14
which may include clinicians who use 
15
telemedicine, in accordance with regu-
16
lations issued by the Administrator of 
17
the Drug Enforcement Administra-
18
tion, to provide services under the cov-
19
ered program; and 
20
(II) the covered program will 
21
provide evidence-based counseling and 
22
behavioral therapies, which may in-
23
clude counseling and therapy adminis-
24
tered through the use of telemedicine, 
25
01:31 Oct 28, 2021
H5697
15 
•HR 5697 IH
as appropriate, to participants as part 
1
of the medication-assisted treatment 
2
provided under the covered program; 
3
and 
4
(B) may include a statement indicating the 
5
number of participants that the applicant ex-
6
pects to serve through the covered program. 
7
(2) MEDICATION-ASSISTED
TREATMENT
COR-
8
RECTIONS AND COMMUNITY REENTRY APPLICATION 
9
REVIEW PANEL.— 
10
(A) IN GENERAL.—Not later than 60 days 
11
after the date of enactment of this Act, the At-
12
torney General shall establish a Medication-As-
13
sisted Treatment Corrections and Community 
14
Reentry Application Review Panel that shall— 
15
(i) be composed of not fewer than 10 
16
individuals and not more than 15 individ-
17
uals; and 
18
(ii) include— 
19
(I) one or more employees, who 
20
are not political appointees, of— 
21
(aa) the Department of Jus-
22
tice; 
23
(bb) the Drug Enforcement 
24
Administration; 
25
01:31 Oct 28, 2021
H5697
16 
•HR 5697 IH
(cc) the Substance Abuse 
1
and Mental Health Service Ad-
2
ministration; 
3
(dd) the National Center for 
4
Injury Prevention and Control at 
5
the Centers for Disease Control 
6
and Prevention; and 
7
(ee) the Office of National 
8
Drug Control Policy; and 
9
(II) other stakeholders who— 
10
(aa) have expert knowledge 
11
relating to the opioid epidemic, 
12
drug treatment, or community 
13
addiction services; and 
14
(bb) represent law enforce-
15
ment organizations and public 
16
health entities. 
17
(B) DUTIES.— 
18
(i) IN GENERAL.—The Panel shall— 
19
(I) review and evaluate applica-
20
tions for covered grants and coopera-
21
tive agreements; and 
22
(II) make recommendations to 
23
the Attorney General relating to the 
24
01:31 Oct 28, 2021
H5697
17 
•HR 5697 IH
awarding of covered grants and coop-
1
erative agreements. 
2
(ii) RURAL COMMUNITIES.—In review-
3
ing and evaluating applications under 
4
clause (i), the Panel shall take into consid-
5
eration the unique circumstances, including 
6
the lack of resources relating to the treat-
7
ment of opioid use disorder, faced by rural 
8
States and units of local government. 
9
(C) TERMINATION.—The Panel shall ter-
10
minate on the last day of fiscal year 2025. 
11
(3) PUBLICATION
OF
CRITERIA
IN
FEDERAL 
12
REGISTER.—Not later than 90 days after the date of 
13
enactment of this Act, the Attorney General, in con-
14
sultation with the Panel, shall publish in the Federal 
15
Register— 
16
(A) the process through which applications 
17
submitted under paragraph (1) shall be sub-
18
mitted and evaluated; and 
19
(B) the criteria used in awarding covered 
20
grants and cooperative agreements. 
21
(f) DURATION.—A covered grant or cooperative 
22
agreement shall be for a period of not more than 4 years, 
23
except that the Attorney General may extend the term of 
24
a covered grant or cooperative agreement based on out-
25
01:31 Oct 28, 2021
H5697
18 
•HR 5697 IH
come data or extenuating circumstances relating to the 
1
covered program carried out under the covered grant or 
2
cooperative agreement. 
3
(g) REPORT.— 
4
(1) IN GENERAL.—Not later than 2 years after 
5
the date on which a State or unit of local govern-
6
ment is awarded a covered grant or cooperative 
7
agreement, and each year thereafter until the date 
8
that is 1 year after the date on which the period of 
9
the covered grant or cooperative agreement ends, the 
10
State or unit of local government shall submit a re-
11
port to the Attorney General that includes informa-
12
tion relating to the covered program carried out by 
13
the State or unit of local government, including in-
14
formation relating to— 
15
(A) the goals of the covered program; 
16
(B) any evidence-based interventions car-
17
ried out under the covered program; 
18
(C) outcomes of the covered program, 
19
which shall— 
20
(i) be reported in a manner that dis-
21
tinguishes the outcomes based on the cat-
22
egories of, with respect to the participants 
23
in the covered program— 
24
01:31 Oct 28, 2021
H5697
19 
•HR 5697 IH
(I) the race of the participants; 
1
and 
2
(II) the gender of the partici-
3
pants; and 
4
(ii) include information relating to the 
5
rate of reincarceration among participants 
6
in the covered program; and 
7
(D) expenditures under the covered pro-
8
gram. 
9
(2) PUBLICATION.— 
10
(A) AWARDEE.—A State or unit of local 
11
government that submits a report under para-
12
graph (1) shall make the report publicly avail-
13
able on— 
14
(i) the website of each correctional fa-
15
cility at which the State or unit of local 
16
government carried out the covered grant 
17
program; and 
18
(ii) if a correctional facility at which 
19
the State or unit of local government car-
20
ried out the covered grant program does 
21
not operate a website, the website of the 
22
State or unit of local government. 
23
(B) ATTORNEY GENERAL.—The Attorney 
24
General shall make each report received under 
25
01:31 Oct 28, 2021
H5697
20 
•HR 5697 IH
paragraph (1) publicly available on the website 
1
of the National Institute of Corrections. 
2
(3) SUBMISSION TO CONGRESS.—Not later than 
3
2 years after the date on which the Attorney Gen-
4
eral awards the first covered grant or cooperative 
5
agreement, and each year thereafter, the Attorney 
6
General shall submit to the Committee on the Judi-
7
ciary of the Senate and the Committee on the Judi-
8
ciary of the House of Representatives a summary 
9
and compilation of the reports that the Attorney 
10
General has received under paragraph (1) during the 
11
year preceding the date on which the Attorney Gen-
12
eral submits the summary and compilation. 
13
(h) AUTHORIZATION OF APPROPRIATIONS.—There is 
14
authorized to be appropriated $50,000,000 to carry out 
15
this section for each of fiscal years 2022 through 2025. 
16
Æ 
01:31 Oct 28, 2021
H5697
